Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Feb 18, 2011 FORM 8-K
SC 13G/A Feb 14, 2011 DOC ONE
8-K Jan 27, 2011 FORM 8-K
SC 13G Jan 25, 2011
8-K Jan 24, 2011 FORM 8-K
SC 13D/A Jan 20, 2011
8-K Jan 19, 2011 FORM 8-K
EFFECT Jan 13, 2011
S-3 Jan 10, 2011 FORM S-3
8-K Jan 4, 2011 FORM 8-K
UPLOAD Dec 30, 2010
CT ORDER Dec 7, 2010
8-K Nov 29, 2010 FORM 8-K
CORRESP Nov 24, 2010
UPLOAD Nov 16, 2010
8-K Nov 10, 2010 FORM 8-K
10-Q Nov 8, 2010 FORM 10-Q
8-K Nov 2, 2010 FORM 8-K
8-K Oct 25, 2010 FORM 8-K
CORRESP Oct 12, 2010
4 Oct 8, 2010 MAIN DOCUMENT DESCRIPTION
ARS Oct 7, 2010 AUTO-GENERATED PAPER DOCUMENT
4 Oct 6, 2010 MAIN DOCUMENT DESCRIPTION
DEF 14A Oct 4, 2010 DEF 14A
UPLOAD Sep 22, 2010
← Newer Page 26 of 38 · 935 filings Older →